UHMK1 has been detected as an autoantibody biomarker for serous ovarian cancer using an ELISA platform against a total of 153 serum samples (63 cases with 30 benign disease controls and 60 healthy controls) (20). Here, UHMK1 is linked to ovarian serous adenocarcinoma.